McLaren, Robbie

Robbie McLaren

Partner

robbie.mclaren@lw.com
    McLaren, Robbie

    Robbie McLaren

    Partner

    robbie.mclaren@lw.com
    "Absolutely outstanding - very knowledgeable, helpful with providing market guidance, is an excellent negotiator, and is a lovely person."

    The Legal 500 UK 2025

    "Great to have on your side - so experienced [and] market savvy."

    The Legal 500 UK 2025

    Ranked – Life Sciences: Transactional

    Chambers UK 2025

    "Industry stalwart and adept at guiding companies from their seed financing through to late stage financing, IPO and beyond."

    The Legal 500 UK 2024

    "Pharmaceuticals sector expert."

    The Legal 500 UK 2019

    Profile

    Robbie McLaren, Global Vice Chair of the firm’s Healthcare & Life Sciences Industry Group, advises healthcare, technology, and life sciences companies across the full corporate life cycle.

    Robbie leverages extensive experience on all sides of a transaction to represent market innovators in:

    • Cross-border mergers and acquisitions
    • Private equity
    • Joint ventures
    • Equity fundraisings
    • Public company representation
    • Carve-outs
    • Asset swaps 

    A recognized leader within the firm, he previously served as Co-Chair of the London Corporate Department.

    Experience

    Robbie’s representative clients include:

    Life Sciences and Healthcare Companies

    • Abcam
    • GlaxoSmithKline
    • Watson Pharmaceuticals / Actavis / Allergan
    • SOBI
    • BenevolentAI
    • BBI Healthcare
    • Norgine
    • Atnahs Pharma (now Pharmanovia)
    • Immedica
    • Pharmathen
    • Theramex
    • Synthon
    • Osler Diagnostics
    • Zogenix

    Private Equity (Healthcare and Life Sciences)

    • Novo Holdings 
    • BC Partners 
    • Nordic Capital 
    • TPG 
    • Patient Square Capital
    • The Carlyle Group
    • CVC
    • Impilo

    Venture Investors

    • Novo Holdings
    • Andera 
    • Burda
    • Coatue

    Technology Companies

    • Bloom & Wild 
    • Vertical Aerospace 
    • Moneybox
    • Darktrace
    • Carbon Clean 
    • Plastic Energy
    • Rivulis
    • Canva
    • Mimecast 
    • Netflix 
    • Intapp 

    Qualifications

    Bar Qualification

    • England and Wales (Solicitor)
    • Scotland (Solicitor)

    Education

    • Diploma in Legal Practice, University of Edinburgh, 2004
    • LLB (Hons), University of Edinburgh, 2003

    Languages Spoken

    • English

    Practices

    Industries

    Recognition

    Read More

    News & Insights

    microbiological pipette in the genetic laboratory
    April 15, 2025 Our Work

    Latham Advises Norgine on Acquisition of Theravia

    A cross-border team represents Norgine in its acquisition of an international pharmaceutical company specializing in cutting-edge treatments for patients with rare and debilitating conditions.
    Germany, Hesse, Frankfurt, European Central Bank, detail of glass façade
    March 27, 2025 Article

    IFLR M&A Report 2025

    Latham lawyers explore key trends, regulatory changes, and market drivers shaping the M&A landscape in Germany, India, the UK, and the US in IFLR’s 2025 M&A Report. 
    Read More